Lyric Biosciences
Latest round
- Seed
Last raised
- Dec 2025
Total raised
- $6.6M
Investors
- 6
About Lyric Biosciences
Lyric Biosciences Inc.Founded in 2024, Lyric Biosciences Inc. operates from its headquarters in San Francisco, US, focusing on the development of human immunoglobulin therapies. In December 2025, Lyric Biosciences Inc., Ltd.Lyric Bio, Inc. specializes in the development and manufacturing of human immunoglobulin (Ig) products, utilizing proprietary bioreactor technology that mimics biological tissue. Their core innovation involves a novel laser-printed cellular substrate that supports ultra-high-density cell growth, enabling the continuous production of human Ig from a single donor. This advancement significantly reduces the reliance on traditional blood and plasma donations, where an average of 10 plasma donations are typically needed to produce one dose of intravenous immunoglobulin (IvIg). By providing a more stable and scalable supply of Ig therapies, Lyric Bio aims to address global shortages of critical therapeutics used in the treatment of over 100 diseases.Lyric Bio generates revenue through direct partnerships and collaborations with pharmaceutical companies and healthcare providers that require human immunoglobulin therapies. The company structures transactions to ensure a consistent supply of its products, leveraging its innovative manufacturing processes to offer high-quality Ig products. Customers may enter into agreements based on volume purchase contracts, allowing for predictable pricing and enhanced supply chain stability. Their flagship products include various formulations of intravenous and subcutaneous immunoglobulin, specifically designed to meet the needs of healthcare systems and patients. Pricing plans are tailored to the scale of production and the specific therapeutic requirements of clients, facilitating a robust revenue model centered around delivering critical therapeutics efficiently.
Who invested in Lyric Biosciences
6 investors across 2 rounds
See all investors in Lyric Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lyric Biosciences
Who invested in Lyric Biosciences?
Lyric Biosciences has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lyric Biosciences raised?
Lyric Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Lyric Biosciences last raise money?
Lyric Biosciences's most recent round on record is a Seed, in Dec 2025.
What does Lyric Biosciences do?
Lyric Biosciences is a biotechnology company.
Where is Lyric Biosciences headquartered?
Lyric Biosciences is headquartered in San Francisco, US.
Which VCs invest in companies like Lyric Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lyric Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Lyric Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.